Showing results (11-20 of 14) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Internal Medicine|February 3, 2022
PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin-treated patients with very high apolipoprotein(a) concentrationQidi Ying, Dick C Chan, Jing Pang, et al.Cell Death & Disease|March 6, 2019
Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatmentQian Yu, Minda Zhang, Qidi Ying, et al.Metabolism: Clinical and Experimental|April 3, 2020
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)Gerald F Watts, Dick C Chan, Jing Pang, et al.Journal of Clinical Lipidology|August 19, 2023
Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid?Natalie C Ward, Qidi Ying, Dick C Chan, et al.Pageof 2